Glòria Garrabou

Research group

Hereditary metabolic diseases and muscular diseases Group leader (R4-UB)

garrabou@clinic.cat 0000-0001-8973-9933

Featured publications

Unravelling inclusion body myositis using a patient-derived fibroblast model

Authors: Cantó-Santos J; Valls-Roca L; Tobías E; García-García FJ; Guitart-Mampel M; Esteve-Codina A; Martín-Mur B; Casado M; Artuch R; Solsona-Vilarrasa E; Fernandez-Checa JC; García-Ruiz C; Rentero C; Enrich C; Moreno-Lozano PJ; Milisenda JC; Cardellach F; Grau-Junyent JM; Garrabou G.

Reference: Journal Of Cachexia Sarcopenia And Muscle 2023.
Multicentric Standardization of Protocols for the Diagnosis of Human Mitochondrial Respiratory Chain Defects

Authors: Bujan N, Morén C, García-García FJ, Blázquez A, Carnicer C, Cortés AB, González C, López-Gallardo E, Lozano E, Moliner S, Gort L, Tobías E, Delmiro A, Martin MÁ, Fernández-Moreno MÁ, Ruiz-Pesini E, Garcia-Arumí E, Rodríguez-Aguilera JC, Garrabou G .

Reference: Antioxidants 2022.
Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus

Authors: Juarez-Flores, DL; Ezquerra, M; Gonzalez-Casacuberta, I; Ormazabal, A; Moren, C; Tolosa, E; Fucho, R; Guitart-Mampel, M; Casado, M; Valldeoriola, F; de la Torre-Lara, J; Munoz, E; Tobias, E; Compta, Y; Garcia-Garcia, FJ; Garcia-Ruiz, C; Fernandez-Checa, JC; Marti, MJ; Grau, JM; Cardellach, F; Artuch, R; Fernandez-Santiago, R; Garrabou, G.

Reference: Antioxidants 2020.
The impact of mitochondrial deficiencies in neuromuscular diseases

Authors: Cantó-Santos J; Grau-Junyent JM; Garrabou G.

Reference: Antioxidants 2020.
Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected Patients

Authors: Bano, Maria; Moren, Constanza; Barroso, Sergio; Juarez, Diana Luz; Guitart-Mampel, Mariona; Gonzalez-Casacuberta, Ingrid; Canto-Santos, Judith; Lozano, Ester; Leon, Agathe; Pedrol, Enric; Miro, Oscar; Tobias, Ester; Mallolas, Josep; Rojas, Jhon F.; Cardellach, Francesc; Martinez, Esteban; Garrabou, Gloria;.

Reference: Frontiers In Genetics 2020.
Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration

Authors: González-Casacuberta I; Juárez-Flores D; Morén C; Garrabou G.

Reference: Frontiers In Neuroscience 2019.
Mitochondrial implications in human pregnancies with intrauterine growth restriction and associated cardiac remodelling

Authors: Guitart-Mampel M, Juarez-Flores DL, Youssef L, Moren C, Garcia-Otero L, Roca-Agujetas V, Catalan-Garcia M, Gonzalez-Casacuberta I, Tobias E, Milisenda JC, Grau JM, Crispi F, Gratacos E, Cardellach F, Garrabou G .

Reference: Journal Of Cellular And Molecular Medicine 2019.
Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson's disease

Authors: Juárez-Flores DL, González-Casacuberta I, Ezquerra M, Bañó M, Carmona-Pontaque F, Catalán-García M, Guitart-Mampel M, Rivero JJ, Tobias E, Milisenda JC, Tolosa E, Marti MJ, Fernández-Santiago R, Cardellach F, Morén C, Garrabou G .

Reference: Journal Of Translational Medicine 2018.
Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations

Authors: González-Casacuberta I, Morén C, Juárez-Flores DL, Esteve-Codina A, Sierra C, Catalán-García M, Guitart-Mampel M, Tobías E, Milisenda JC, Pont-Sunyer C, Martí MJ, Cardellach F, Tolosa E, Artuch R, Ezquerra M, Fernández-Santiago R, Garrabou G .

Reference: Neurobiology Of Aging 2018.

Featured Projects

Miositis por cuerpos de inclusión esporádica: desarrollo de nuevos modelos celulares para la identificación de biomarcadores y estrategias terapéuticas.

Principal investigator: Josep Maria Grau

Code: PI1800498

Duration: 01/01/2019 - 30/12/2021
Implementación de la medicina personalitzada basada en la genómica en casos de enfermedades minoritarias no diagnosticadas

Code: PI044859

Duration: 01/01/2017 - 01/01/2019
Role of the novel cardiomyokines FGF21 and Mtrnl on cardiac damage induced by alcoholism and arterial hypertension

Principal investigator: Constanza Morén Núñez

Code: 87/C/2015

Duration: 01/01/2016 - 01/01/2018
Alteraciones mitocondriales en modelos celulares de la enfermedad de Parkinson (LRRK2 y Parkin): Potencial terapéutico de moduladores de la función mitocondrial

Principal investigator: Ruben Garcia

Duration: 01/01/2012 - 01/01/2016

Glòria Garrabou

Research group

Featured publications

Unravelling inclusion body myositis using a patient-derived fibroblast model

Multicentric Standardization of Protocols for the Diagnosis of Human Mitochondrial Respiratory Chain Defects

Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus

The impact of mitochondrial deficiencies in neuromuscular diseases

Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected Patients

Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration

Mitochondrial implications in human pregnancies with intrauterine growth restriction and associated cardiac remodelling

Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson's disease

Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations

Featured Projects

Miositis por cuerpos de inclusión esporádica: desarrollo de nuevos modelos celulares para la identificación de biomarcadores y estrategias terapéuticas.

Implementación de la medicina personalitzada basada en la genómica en casos de enfermedades minoritarias no diagnosticadas

Role of the novel cardiomyokines FGF21 and Mtrnl on cardiac damage induced by alcoholism and arterial hypertension

Alteraciones mitocondriales en modelos celulares de la enfermedad de Parkinson (LRRK2 y Parkin): Potencial terapéutico de moduladores de la función mitocondrial

Subscribe to the Newsletter of Clínic